Chemours Co (CC) is Reiterated by Barclays to Overweight, Raises Price Target to $ 15

Chemours Co (CC) was Reiterated by Barclays to “Overweight” according to the research note released today. The brokerage firm has raised the Price Target to $ 15 from a previous price target of $14 . Barclays advised their investors in a research report released on May 9, 2016.

Many Wall Street Analysts have commented on Chemours Co. Chemours Co was Upgraded by Goldman to ” Buy” on Mar 14, 2016. Chemours Co was Downgraded by Jefferies to ” Hold” on Feb 16, 2016.

On the company’s financial health, Chemours Co reported $0.06 EPS for the quarter, based on the information available during the earnings call on May 2, 2016. Analyst had a consensus estimate of $0.06. The company had revenue of $1297.00 million for the quarter, compared to analysts expectations of $1267.06 million. The company’s revenue was down -4.8 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $0.33 EPS.

Chemours Co opened for trading at $9.9 and hit $10.29 on the upside on Friday, eventually ending the session at $10.26, with a gain of 3.95% or 0.39 points. The heightened volatility saw the trading volume jump to 21,54,104 shares. Company has a market cap of $1,861 M.

In a different news, on May 6, 2016, Bradley J Bell (director) purchased 10,000 shares at $9.65 per share price. According to the SEC, on Feb 29, 2016, Stephen D Newlin (director) purchased 10,000 shares at $4.95 per share price. On Feb 12, 2016, Mark Newman (SVP and CFO) sold 16 shares at $9.37 per share price, according to the Form-4 filing with the securities and exchange commission.

The Chemours Company (Chemours) is a provider of performance chemicals. The Company delivers solutions with a range of industrial and specialty chemical products for markets including plastics and coatings refrigeration and air conditioning general industrial and mining and oil refining. The Company operates through three segments: Titanium Technologies Fluoroproducts and Chemical Solutions. The Titanium Technologies segment is a producer of titanium dioxide (TiO2) under the brands including Ti-Pure and Vantage. Its Fluoroproducts segment is a provider of fluoroproducts under the brands including Suva ISCEON Freon Opteon Teflon Tefzel Viton Krytox Formacel Dymel FM 200 Nafion and Capstone. Its Chemical Solutions segment is a provider of industrial and specialty performance chemicals under the brands including Virkon and Oxone. The Company’s products include titanium dioxide refrigerants industrial fluoropolymer resins sodium cyanide sulfuric acid and aniline.

Chemours Co

Leave a Reply

Chemours Co - Is it time to Sell?

Top Brokerage Firms are advising their investors on Chemours Co. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.